TP53 and acute lymphoblastic leukemia: Furthermore, P53 phosphorylation and BAX expression were not suppressed by imatinib pretreatment, further confirming the antiapoptotic effect of C-MYC in Sup-B15, different from that in Ph− B-ALL cells (Fig. 4D).